Aspiring global player
Within the next decade, LIFEPharma will grow to become a billion-dollar enterprise in finished dosage medication, with a competitive presence in the US, Europe, Canada, Russia, Brazil, South Africa, Mexico, Japan, and China, as well as licensing arrangements in other parts of the world.
Besides the GCC region and Africa, LIFEPharma is already exporting to Asia, Europe, and North and South America. Aiming to become a global player in pharmaceutical manufacturing, LIFEPharma has created production facilities of the highest standard and achieved accreditation from many regional and international health authorities.
The company's current Dubai factory manufactures tablets, capsules, liquid suspensions, and syrups. It has been approved by the European Medical Agency, as well as health ministries in the UAE, Kenya, Ethiopia, Uganda, Bahrain, Ivory Coast, and Iraq.
LIFEPharma has embarked on major expansion, investing over $250 million in a new pharmaceutical research and manufacturing plant in Abu Dhabi, the first in the Gulf region to produce anti-cancer drugs. The new plant will adhere to international standards specified by globally recognised authorities such as the UK's Medicines and Healthcare Products Regulatory Agency, and the US Food and Drug Administration.
The new factory will occupy a 17,000m2 site in Khalifa Industrial Zone (Kizad). Alongside cancer control and research, it will produce vaccines, sterile injections, and solid dosage oral medication to treat illnesses such as hepatitis and influenza.
Click here to know more about LIFEPharma
We are open 24/7 for assistance